who medicines strategy - libdoc.who.int - World Health Organization

More documents

Recommendations

Info

WHO MEDICINES STRATEGY 2004-2007 | 34EO 1.4Human resources capacity increasedin the pharmaceutical sectorthrough education and trainingprogrammes to develop capacityand to motivate and retainpersonnel in sufficient numberswithin a clearly defined andorganized structureRationaleEffective medicines policy implementation canonly be achieved when appropriate numbers ofwell-trained and motivated pharmaceutical staffare employed and functioning in an efficientway. Motivation arises as a result of an effectivepolicy, a clear understanding of the rationale andobjectives of the policy, adequate remunerationfor work, well-defined roles and responsibilities,and clear standards for performance.ProgressIn 2002 alone, WHO support to countriesincluded the training of nearly 900 healthprofessionals in: medicines regulation, qualityassurance, and anti-counterfeit activities; rationaluse of medicines by health professionals; publicsector medicines supply; national medicinespolicy development and monitoring; the impactof trade agreements on access to medicines;medicines financing and pricing; improvingmedicines use by consumers; and establishmentof pharmaceutical norms and standards 9 . Thesetraining programmes were held in all six WHOregions, in English, French, and Spanish.Challenges remainingIn many countries, policy implementation isconstrained by the lack of sufficient numbers ofadequately trained and motivated pharmaceuticalstaff and difficulties in retaining trained staff. Insome sub-Saharan countries there are less than10 pharmacists in the public service. In addition,other health professionals are not adequatelyeducated about the essential medicinesconcept, which is central to understandingand implementing a national medicines policy.Although WHO offers a number of trainingcourses, the challenge is to ensure that coursesare integrated into larger strategies to build humancapacity in pharmaceuticals, that appropriateparticipants are identified and selected, and thatthey receive follow-up support.Meeting the challenges 2004-2007Over the next four years WHO will:> provide technical assistance to governmentswith severe staff shortages to help themaddress key policy issues (including supportin the development of strategies to train andretain pharmaceutical staff and to improve theknowledge of all health professionals in theconcept of essential medicines).> work with universities to ensure theintegration of the essential medicines conceptin curricula for health professionals.> maximize the impact of WHO trainingcourses through: ensuring that courses fit intobroader strategies to increase human resourcecapacity in pharmaceuticals; courses arefocused on relevant topics, regularly updated,and available in the appropriate languages;participants are carefully selected and receivefollow-up support.
COMPONENTS OF THE STRATEGY | 35Figure 5: Medicines training for health professionals in 20014443412525522513551215555212345Access to essential medicines – medicines policy issues, pharmacoeconomics, drug managementMedicines quality – good manufacturing practices, TB drug quality, combating counterfeit drugs,good laboratory practices, managing the analytic laboratory, thin layer chromatographyMedicines regulation – basic training, computer-assisted registration, good clinical practiceMonitoring medicines safety and use – pharmacovigilance, the study of adverse reactions,anatomical therapeutic chemical classification system/defined daily dosesRational use of medicines – promoting rational drug use, teaching rational pharmacotherapy,promoting rational drug use in the community, drugs and therapeutics committees, data analysis forrational use researchOUTCOME INDICATORS1999 2003 2007No. of countries that provide both basic and continuingeducation programmes for pharmacists#REPORTING % TARGET#REPORTING % TARGET54/85 64% na 34/110 31% 35%
Page 10 and 11: WHO MEDICINES STRATEGY 2004-2007 |x
Page 12 and 13: WHO MEDICINES STRATEGY 2004-2007 |x
Page 14 and 15: WHO MEDICINES STRATEGY 2004-2007 |
Page 23: MEDICINESAND PUBLIC HEALTH
Page 96 and 97:
WHO MEDICINES STRATEGY 2004-2007 |
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 157 and 158:
REFERENCES
Page 159 and 160:
REFERENCES | 1471Annual report 2000
Page 161 and 162:
REFERENCES | 14912 th Model List of
show all

who medicines strategy - libdoc.who.int - World Health Organization

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?